Plenary Session

387 Episodo

1. QuANTUM - Quizartinib Front Line - Ethics of Global Trials

   Publicado: 15/6/2022
2. 4.67 Teclistimab for R/R Multiple Myeloma

   Publicado: 9/6/2022
3. 4.66 PD1 Ab for MSI H Stage II/ III Rectal Cancer; A 100% CR rate??

   Publicado: 8/6/2022
4. 4.65 DESTINY BREAST 04 - A complex trial to deconstruct

   Publicado: 7/6/2022
5. 4.64 - DETERMINATION - Should we still use transplant Myeloma?

   Publicado: 6/6/2022
6. 4.63 - ASCO22 - DYNAMIC - Can CT DNA Allow us to Give Less Chemo in Stage II Colon Cancer

   Publicado: 5/6/2022
7. 4.62 - SHINE - Ibrutinib BR vs BR; Limitations to the trial

   Publicado: 4/6/2022
8. 4.61 - How CDC's Vaccine Safety Missed Cases Of Myocarditis

   Publicado: 27/5/2022
9. 4.60 - NEW JCO paper - AML, EFS, CR, CRi, and Surrogate validation - FDA & Methods

   Publicado: 21/5/2022
10. 4.59 - How to be a better reader of case control studies

    Publicado: 17/5/2022
11. 4.58 - Myeloma is a broken field - New BLOOD Paper!

    Publicado: 14/5/2022
12. 4.57 - COVID19 and the Failures of Public Health w/ Leslie Bienen

    Publicado: 6/5/2022
13. 4.56 - Fifth Installment of the brilliant Zeb Jamrozik

    Publicado: 4/5/2022
14. 4.55 - Compilation Of Recent Covid Monologues

    Publicado: 1/5/2022
15. 4.54 - Eric Collisson Professor, GI Oncologist, Physician Scientist

    Publicado: 30/4/2022
16. 4.53 John Ioannidis lectures the VKPrasad Lab about COVID19

    Publicado: 27/4/2022
17. 4.52 Vinay Prasad Gives a Lecture on COVID19 to a General Audience

    Publicado: 24/4/2022
18. 4.51 - Vinay Prasad is Interviewed by Kristina Jenei About Academic Medicine

    Publicado: 22/4/2022
19. 4.50 - Ivosidenib & Aza vs Aza, the AGILE, 6 huge problems; Journal club

    Publicado: 21/4/2022
20. 4.49 - Malignant Book Club Part 3 Audio

    Publicado: 15/4/2022